🔗 Share this article

Texas Attorney General Ken Paxton is suing the producers of acetaminophen, alleging the firms concealed safety concerns that the drug created to children's brain development.

The court filing comes thirty days after President Donald Trump promoted an unsubstantiated connection between consuming Tylenol - alternatively called acetaminophen - while pregnant and autism in offspring.

Paxton is filing suit against the pharmaceutical giant, which previously sold the medication, the sole analgesic suggested for expectant mothers, and Kenvue, which currently produces it.

In a official comment, he said they "betrayed America by gaining financially from discomfort and promoting medication regardless of the potential hazards."

Kenvue says there is insufficient reliable data tying acetaminophen to autism.

"These companies misled for generations, intentionally threatening millions to increase profits," Paxton, a Republican, declared.

The company stated officially that it was "deeply concerned by the spread of false claims on the safety of acetaminophen and the possible consequences that could have on the well-being of women and children in America."

On its official site, Kenvue also said it had "regularly reviewed the relevant science and there is lacking reliable evidence that demonstrates a established connection between using paracetamol and autism spectrum disorder."

Groups acting on behalf of medical professionals and health professionals concur.

The leading OB-GYN organization has said acetaminophen - the main ingredient in acetaminophen - is among limited choices for expectant mothers to manage pain and elevated temperature, which can create significant medical dangers if ignored.

"In multiple decades of studies on the consumption of acetaminophen in pregnancy, no reliable research has successfully concluded that the use of acetaminophen in any stage of pregnancy leads to brain development issues in children," the organization said.

The court filing cites recent announcements from the former administration in claiming the medication is potentially dangerous.

Recently, Trump raised alarms from medical authorities when he instructed pregnant women to "resist strongly" not to consume Tylenol when sick.

Federal regulators then published an announcement that medical professionals should contemplate reducing the use of acetaminophen, while also mentioning that "a direct connection" between the medication and autism in minors has not been established.

The Health Department head RFK Jr, who oversees the FDA, had promised in April to undertake "a massive testing and research effort" that would identify the source of autism spectrum disorder in a matter of months.

But experts warned that identifying a single cause of autism spectrum disorder - believed by scientists to be the result of a complex mix of genetic and external influences - would not be simple.

Autism is a type of permanent neurological difference and impairment that impacts how people perceive and interact with the environment, and is recognized using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is campaigning for federal office - asserts Kenvue and J&J "willfully ignored and tried to quiet the science" around paracetamol and autism spectrum disorder.

This legal action aims to force the firms "remove any promotional materials" that claims Tylenol is reliable for expectant mothers.

The court case mirrors the concerns of a collection of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who filed suit against the manufacturers of Tylenol in recently.

Judicial authorities rejected the legal action, stating research from the family's specialists was inconclusive.